As it happened: UK's coronavirus infection levels continue to fall - BBC News
About 105,000 people in the UK would test positive, statistics suggest, down from 130,000 a week before.
China has now administered 211 million vaccine doses, only eight million fewer doses than the US. There is some expectation by next week, China will have surpassed the US and have administered more vaccine doses than anywhere else in the world.

Four different vaccines have currently been approved in China for public use, all of which have been developed within the country.

However, others are on the way; it is possible that another vaccine co-developed by German’s BioNTech may become available within the country “before July”.

According to the national Global Times newspaper, “the Fosun Pharma/BioNTech vaccine will be the first foreign-developed Covid-19 vaccine that China will import”.

Meanwhile, Chinese firm CanSino is set to begin vaccine trials next week using an inhaled vaccine candidate. Global Times said last month an inhaled vaccine would “be a less painful and more accessible” alternative to an injection, “especially for children and vulnerable people”.

China’s main vaccines, Sinopharm and Sinovac also may soon receive authorisation from the World Health Organization to be included in the Covax global vaccine distribution programme.

According to the independent South China Morning Post, Chinese vaccines are in the “final stage of the WHO approval process”. Review meetings to discuss both are set for 3 May. They have been hindered to date by insufficient data on the elderly and people with underlying health condition, given that China has prioritised vaccination among people aged 18 to 59.